{"disease":{"id":"amyotrophic-lateral-sclerosis-als","name":"amyotrophic lateral sclerosis als"},"drugs":{"marketed":[{"drug_id":"riltozinameran-12-years-of-age-and-older","indication_name":"Amyotrophic lateral sclerosis (ALS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Riltozinameran 12 Years of age and older","generic_name":"riltozinameran-12-years-of-age-and-older","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":34,"revenue":null,"mechanism":"Mechanism of action is not specified on Wikipedia."},{"drug_id":"neurontin","indication_name":"Seizures associated with amyotrophic lateral sclerosis (ALS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neurontin","generic_name":"Gabapentin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"α2δ subunit of voltage-activated calcium channels","drug_class":"Antiepileptic/Analgesic","quality_score":79,"revenue":null,"mechanism":"Gabapentin binds with high-affinity to α2δ subunit of voltage-activated calcium channels; precise mechanism unknown."}],"pipeline":[{"drug_id":"cromolyn-sodium","indication_name":"Amyotrophic Lateral Sclerosis (ALS)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CROMOLYN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"Mast cells","drug_class":"Mast cell stabilizer","quality_score":30,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":2,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03233646","title":"Retinal Imaging in Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04715399","title":"UPenn Observational Research Repository on Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07233148","title":"Healing ALS Registry Observational Study (HAROS)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Healing Advocates Registry and Ministry","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT07454733","title":"Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Trustees of Dartmouth College","has_results":false},{"nct_id":"NCT07202494","title":"Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT07174492","title":"Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":412,"lead_sponsor_name":"AB Science","has_results":false},{"nct_id":"NCT03800524","title":"Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":337,"lead_sponsor_name":"Humanitas Mirasole SpA","has_results":false},{"nct_id":"NCT02936635","title":"A Study for Patients Who Completed VITALITY-ALS (CY 4031)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT06643481","title":"A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":251,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06917924","title":"A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"A.O.U. Città della Salute e della Scienza","has_results":false},{"nct_id":"NCT06973629","title":"Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Brainstorm-Cell Therapeutics","has_results":false},{"nct_id":"NCT03280056","title":"Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Brainstorm-Cell Therapeutics","has_results":true},{"nct_id":"NCT07138014","title":"FHND1002 for ALS Treatment: Phase 2","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07410806","title":"HEALEY ALS Platform Trial - Regimen I NUZ-001","phase":"PHASE2, PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Merit E. Cudkowicz, MD","has_results":false},{"nct_id":"NCT06819124","title":"Examining Interactions Between PALS and Caregivers","phase":"NA","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Penn State University","has_results":false},{"nct_id":"NCT04577404","title":"Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Tanabe Pharma America, Inc.","has_results":true},{"nct_id":"NCT06765499","title":"The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT01786603","title":"Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Richard Barohn, MD","has_results":true},{"nct_id":"NCT06877143","title":"Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"University of Ulm","has_results":false},{"nct_id":"NCT06782958","title":"Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":72,"lead_sponsor_name":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05395624","title":"Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":65,"lead_sponsor_name":"Ashvattha Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06834269","title":"Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Campus Bio-Medico University","has_results":false},{"nct_id":"NCT03088839","title":"Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Neuromed IRCCS","has_results":false},{"nct_id":"NCT06608004","title":"Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT06429059","title":"ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06819358","title":"Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical Study","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06769620","title":"A First in Human Study of ORT247 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Orthogonal Neuroscience Inc.","has_results":false},{"nct_id":"NCT03580616","title":"Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Elijah W. Stommel","has_results":true},{"nct_id":"NCT06351592","title":"First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04220021","title":"Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT07143656","title":"Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Biocells Medical","has_results":false},{"nct_id":"NCT03645031","title":"Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT07169175","title":"A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":21,"lead_sponsor_name":"SineuGene Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT06968468","title":"Resiliency Intervention for Patients With ALS and Their Care-Partners","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07017946","title":"Intestinal Microbiome Transplant in ALS","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT07170865","title":"Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06903286","title":"Extension Study of Participants From SPG302-ALS-001","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Spinogenix","has_results":false},{"nct_id":"NCT07257302","title":"Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"National Center of Neurology and Psychiatry, Japan","has_results":false},{"nct_id":"NCT04866771","title":"Remotely Supervised tDCS for Slowing ALS Disease Progression","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"University of Illinois at Chicago","has_results":true},{"nct_id":"NCT07118319","title":"The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06249412","title":"The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":11,"lead_sponsor_name":"Groupe Hospitalier du Havre","has_results":false},{"nct_id":"NCT07187388","title":"Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Nova Southeastern University","has_results":false},{"nct_id":"NCT06493279","title":"Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"RJK Biopharma Ltd","has_results":false},{"nct_id":"NCT06645197","title":"An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":7,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06700304","title":"CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices","phase":"NA","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Neuralink Corp","has_results":false},{"nct_id":"NCT07298486","title":"Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5,"lead_sponsor_name":"Nova Southeastern University","has_results":false},{"nct_id":"NCT06849115","title":"Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"ChaodongWang","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}